In fact, companies like Pfizer and Amgen recently have spent more money in buying back their shares to boost their stock price than on R&amp;D, but that's a whole different TED Talk which one day I'd be fascinated to tell you about.
Kompanite si Pfizer she Amgen kane harxhuar me shume para ne ri-blerjen e aksioneve te tyre per te rritur cmimin e aksioneve ne total sesa ne kerkim dhe zhvillim. Por kjo eshte nje teme tjeter, te cilen ne fakt mund ta kemi ne nje tjeter bisede te TED.